Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Pittsburgh, Pennsylvania

Phase 2 colorectal cancer trials in Pittsburgh, PA

5 Phase 2 colorectal cancer studies are recruiting participants at sites in Pittsburgh as of November 18, 2026, according to ClinicalTrials.gov. Colorectal Phase 2 Trials can help you understand your options and connect with a study team.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Pittsburgh at a glance

  • 5 studies are recruiting at a site in Pittsburgh.
  • By phase: Phase 2 (5).
  • By sponsor: university, hospital or other (3), industry (2).
  • Most recent update to one of these records: November 3, 2026.

Studies recruiting in Pittsburgh

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Allegheny General Hospital · West Penn Hospital
    Registry record
    NCT05673148 · updated
  2. A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Criterium, Inc.
    Study site
    UPMC / University of Pittsburgh Medical Center
    Registry record
    NCT06992258 · updated
  3. A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    NSABP Foundation Inc
    Study sites
    Allegheny General Hospital · Magee-Womens Hospital of UPMC
    Registry record
    NCT07058012 · updated
  4. A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Kahr Bio Australia Pty Ltd
    Study site
    UPMC Hillman Cancer Center
    Registry record
    NCT07235293 · updated
  5. Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Diwakar Davar
    Study site
    UPMC Hillman Cancer Center
    Registry record
    NCT07223424 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Pittsburgh, PA on ClinicalTrials.gov.

Ask about studies near Pittsburgh

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call